Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04332926 · ClinicalTrials.gov registry record · NA
Effects of E-Cigarette Nicotine Content in Smokers (Nicotine Flux Study)
A NA study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT04332926 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 44 participants.
The verdict
NCT04332926, a NA study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
This study aims to better understand how e-cigarettes (ECIG) nicotine flux impacts several behavioral economic measures of abuse liability.
Interventions
- OTHER Tobacco product administration and assessment, own brand cigarettes
- OTHER Tobacco product administration and assessment, ECIG 30 Watts, 0 mg/ml nicotine
- OTHER Tobacco product administration and assessment, ECIG 30 Watts, 8 mg/ml nicotine
- OTHER Tobacco product administration and assessment, ECIG 30 Watts, 15 mg/ml nicotine
- OTHER Tobacco product administration and assessment, ECIG 30 Watts, 30 mg/ml nicotine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2021-01-05 |
| Est. Completion | 2023-09-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04332926
The ClinicalTrials.gov registry entry for NCT04332926 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Tobacco product administration and assessment, own brand cigarettes is the first listed.
NCT04332926 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04332926 about?
NCT04332926 is a clinical study titled "Effects of E-Cigarette Nicotine Content in Smokers (Nicotine Flux Study)". This study aims to better understand how e-cigarettes (ECIG) nicotine flux impacts several behavioral economic measures of abuse liability.
What is the current status of trial NCT04332926?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2021-01-05. Estimated completion is 2023-09-08.
What interventions are being tested in trial NCT04332926?
The interventions under investigation include: Tobacco product administration and assessment, own brand cigarettes (OTHER), Tobacco product administration and assessment, ECIG 30 Watts, 0 mg/ml nicotine (OTHER), Tobacco product administration and assessment, ECIG 30 Watts, 8 mg/ml nicotine (OTHER), Tobacco product administration and assessment, ECIG 30 Watts, 15 mg/ml nicotine (OTHER), Tobacco product administration and assessment, ECIG 30 Watts, 30 mg/ml nicotine (OTHER).
Who is sponsoring clinical trial NCT04332926?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.